The Financial Times is now a majority shareholder in Endpoints News, a vertical covering biopharma. It’s not the first time that the FT grew by acquisition; it acquired Euro startup-focused Sifted in Jan. 2019.
- Posted on
- By Sam Whitmore
- In Notes
The Financial Times is now a majority shareholder in Endpoints News, a vertical covering biopharma. It’s not the first time that the FT grew by acquisition; it acquired Euro startup-focused Sifted in Jan. 2019.